Abstract

Real-World Data From First-Line EGFRm NSCLC Treatment

Full Text

Published Version
Open DOI Link

Topics from this Paper

  • Real-World Data
  • EGFRm NSCLC
  • NSCLC Treatment

Create a personalized feed of these topics

Get Started

Get access to 115M+ research papers

Discover from 40M+ Open access, 2M+ Pre-prints, 9.5M Topics and 32K+ Journals.

Sign Up Now! It's FREE

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

EP1.01-21 Time on Treatment of First-Line PD-1 Inhibitor Monotherapy for Metastatic Non-Small Cell Lung Cancer Patients: Real-World Experience Data
  • Journal of Thoracic Oncology
  • Oct 1, 2019
Relevant
Not Relevant
Abstract 3396: Discovery of BDTX-1535, a novel 4th generation, irreversible, potent, wild type sparing EGFR MasterKey inhibitor that targets oncogenic kinase domain mutations as well as extracellular domain alterations for the treatment of NSCLC and GBM
  • Cancer Research
  • Apr 4, 2023
Relevant
Not Relevant
LBA1_PR: Osimertinib as first-line treatment for EGFR mutation-positive advanced NSCLC: updated efficacy and safety results from two Phase I expansion cohorts
  • Journal of Thoracic Oncology
  • Apr 1, 2016
Relevant
Not Relevant
PC01.02 Real World Research Groups — ROS1ders
  • Journal of Thoracic Oncology
  • Oct 1, 2019
Relevant
Not Relevant
5PSQ-152 Real world efficacy and cost data on patients with metastatic non-small cell lung cancer treated with checkpoint inhibitors in an Italian university hospital in September 2016–2020
  • European Journal of Hospital Pharmacy
  • Mar 1, 2021
Relevant
Not Relevant
PCN323 CHANGE IN TREATMENT PARADIGM OF ALK+ NON-SMALL CELL LUNG CANCER (NSCLC) IN THE ITALIAN REAL PRACTICE
  • Value in Health
  • Nov 1, 2019
Relevant
Not Relevant
EP08.02-108 Osimertinib Long-Term Tolerability in Patients with EGFRm NSCLC Enrolled in the AURA Program or FLAURA Study
  • Journal of Thoracic Oncology
  • Sep 1, 2022
Relevant
Not Relevant
Comparison of platinum agents cisplatin and carboplatin in routine treatment of advanced NSCLC: Results from prospective German TLK cohort study
  • Annals of Oncology
  • Sep 1, 2017
Relevant
Not Relevant
Prognostic Implication of KRAS G12C Mutation in a Real-World KRAS-Mutated Stage IV NSCLC Cohort Treated With Immunotherapy in The Netherlands.
  • JTO clinical and research reports
  • Sep 1, 2023
Relevant
Not Relevant
Exploratory Analysis of Nivolumab Effectiveness with Lab Data in NSCLC pts in Japan: A Multicenter-Retrospective Study
  • Annals of Oncology
  • Oct 1, 2019
Relevant
Not Relevant
First-line treatment of NSCLC with bevacizumab: real world data from an Italian regional based survey
  • Journal of Chemotherapy
  • Jan 2, 2017
Relevant
Not Relevant
Evaluating NSCLC Treatment Options Using Real World Data: Findings from an Oncology Survey Across Eight Countries
  • Value in Health
  • Sep 1, 2018
Relevant
Not Relevant
Real-World Evaluation of Factors for Interstitial Lung Disease Incidence and Radiologic Characteristics in Patients With EGFR T790M–positive NSCLC Treated With Osimertinib in Japan
  • Journal of Thoracic Oncology
  • Dec 1, 2020
Relevant
Not Relevant
Real-word efficacy of osimertinib in patients with metastatic EGFRm NSCLC: An interim analysis from a multi-center study in China
  • Annals of Oncology
  • Nov 1, 2019
Relevant
Not Relevant
Platinum-based chemotherapy combined with endostar in the treatment of advanced NSCLC: A real world study.
  • Journal of Clinical Oncology
  • May 28, 2021
Relevant
Not Relevant
READ MORE FROM

Oncology Times

How Diabetes May Accelerate Blood Cancer Growth
Open Access
Just Published
  • Oncology Times
  • Nov 20, 2023
Relevant
Not Relevant
CAR T-Cell Therapy Survival Outcomes Across Ethnicity & Race
Open Access
Just Published
  • Oncology Times
  • Nov 20, 2023
Relevant
Not Relevant
Reproductive Factors Linked to Lung Cancer Risk in Women
Open Access
Just Published
  • Oncology Times
  • Nov 20, 2023
Relevant
Not Relevant
Technique Highlights How Abnormal RNA Splicing Leads to Disease
Open Access
Just Published
  • Oncology Times
  • Nov 20, 2023
Relevant
Not Relevant
New Treatment Regimen Shows Promise for Bladder Cancer Patients
Open Access
Just Published
  • Oncology Times
  • Nov 20, 2023
Relevant
Not Relevant
Splicing Factor Gene Mutations in Patients With AML
Open Access
Just Published
  • Oncology Times
  • Nov 20, 2023
Relevant
Not Relevant
An Increase in Early-Onset Cancers Among People Under 50
Open Access
Just Published
  • Oncology Times
  • Nov 20, 2023
Relevant
Not Relevant
Real-World Data From First-Line EGFRm NSCLC Treatment
Open Access
Just Published
  • Oncology Times
  • Nov 20, 2023
Relevant
Not Relevant
Cognitive Effects in Prophylactic Cranial Irradiation for Small Cell Lung Cancer
Open Access
Just Published
  • Oncology Times
  • Nov 20, 2023
Relevant
Not Relevant
Soy Expansion Linked to Increase in Childhood Leukemia Deaths
Open Access
Just Published
  • Oncology Times
  • Nov 20, 2023
Relevant
Not Relevant